• Mashup Score: 1

    Janus kinase (JAK) inhibitors have ushered in a new era in alopecia areata (AA). Historically, moderate-to-severe AA was refractory to treatment. JAK inhibitors have changed that; now, treatment of moderate-to-severe AA is possible. Here, we briefly review the history of and rationale for JAK inhibitor treatment of AA, phase 3 clinical trial data, and considerations regarding differences among JAK inhibitors, safety, and patient selection.

    Tweet Tweets with this article
    • Janus kinase (JAK) inhibitors have ushered in a new era in #alopeciaareata (AA). Historically, moderate-to-severe AA was refractory to treatment. JAK inhibitors have changed that; now, treatment of AA is possible. https://t.co/cUq0CWdfdV @Brett_King_ @dermdoctorbritt https://t.co/XWcIYrhRfU

  • Mashup Score: 0
    AAD.org Login - 8 month(s) ago

    Create a non-member account if you are applying for m embership or need to interact with AAD systems. Non-member accounts do not have access to the member-only sections of our

    Tweet Tweets with this article
    • .@TheJEADV study assessed whether exposure to biologics for women with psoriasis is associated with an elevated risk of congenital malformation or miscarriage. Learn more in #DermWorldWeekly - https://t.co/vB2tRsAyui https://t.co/GWd6QzDK6W

    • A @JAADJournals research letter suggests a significant relationship for #atopicdermatitis contributing to the occurrence of #alopeciaareata. Learn more in #DermWorldWeekly - https://t.co/EqM4iTGZyM